Atlas FDA

OMI

2 FDA 510(k) clearances · Product code

FDA profile

Official device name
Multiplex Flow Immunoassay, T. Gondii, Rubella And Cmv
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3510
Medical specialty
Microbiology
FDA definition
The kit is a multiplex immunoassay intended for the quantitative detection of IgG antibodies to Toxoplasma gondii (T. gondii) and Rubella, and qualitative detection of Cytomegalovirus (CMV) IgG in human serum and/ or plasma. Indicated as an aid in the determination of serological status to T. gondii, Rubella and CMV. This kit is not intended for use in screening blood or plasma donors.
Adverse events (MAUDE)
2009: 4 · 2010: 4 · 2011: 9 · 2012: 6
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
BIOPLEX 2200 TORC IGG (K120572)Bio-Rad Laboratories, Inc.2012-03-26
BIOPLEX 2200 SYSTEM TORC IGG KIT, CALIBRATOR SET AND CONTROL SET (K080008)Bio-Rad Laboratories, Inc.2009-02-23

Track OMI automatically

Every clearance here is in the API, with alerts when new ones post.